BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1617640)

  • 1. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.
    Porgador A; Tzehoval E; Katz A; Vadai E; Revel M; Feldman M; Eisenbach L
    Cancer Res; 1992 Jul; 52(13):3679-86. PubMed ID: 1617640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
    Mandelboim O; Feldman M; Eisenbach L
    J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):191-201. PubMed ID: 7905286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
    Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
    J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.
    Porgador A; Bannerji R; Watanabe Y; Feldman M; Gilboa E; Eisenbach L
    J Immunol; 1993 Feb; 150(4):1458-70. PubMed ID: 8432988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-transfected tumor cells modulate the status of CD8(+) and CD4(+) T cells to control tumor growth.
    Hsieh CL; Liu SJ; Shen CR; Chen MY; Hsu SC; Tsai JP; Li YS; Yang CJ; Chong P; Chen HW
    Immunobiology; 2010 Jun; 215(6):486-91. PubMed ID: 19699006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
    Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts.
    Ishiguro H; Kishimoto T; Furuya M; Nagai Y; Watanabe T; Ishikura H
    Cancer Immunol Immunother; 2005 Dec; 54(12):1191-9. PubMed ID: 15846489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
    Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interleukin-6 on the growth of human lung cancer cell line.
    Fu J; Zheng J; Fang W; Wu B
    Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
    Yamit-Hezi A; Plaksin D; Eisenbach L
    Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.